McKesson is engaged in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. Co.'s segments include: U.S. Pharmaceutical, which distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs; International, which provides distribution and services to wholesale, institutional, and retail customers; Medical-Surgical Solutions, which provides medical-surgical supply distribution, logistics, and other services to healthcare providers; and Prescription Technology Solutions, which brings together CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation. The MCK stock yearly return is shown above.
The yearly return on the MCK stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2016 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the MCK annual return calculation with any dividends reinvested as applicable (on ex-dates).
|